stem cell treatment

Hanwha Q Cells, the Q Cells division of Hanwha Solutions Corp., said on Wednesday that it had started a renewable energy generation forecast service...

Samsung Bioepis Co., a South Korean biosimilar firm, announced on Sunday that it has recently launched a new biosimilar drug called SB11 for the tre...

Samsung SDI Co., the world’s No. 6 electric vehicle battery maker, is set to build a plant in the US with General Motors Co., spending about 5...

Cha Biotech, a South Korean biotechnology company, said on Thursday that it agreed to sell its technology for developing eye-cell therapies to Astel...

Singapore's TES, an electronic waste management specialist and subsidiary of South Korea's SK Ecoplant Co., will jointly pursue the development of e...

The Electronics and Telecommunications Research Institute (ETRI), a non-profit government-funded research institute in South Korea, said on Tuesday ...

China’s Contemporary Amperex Technology Co. (CATL), the leading global electric vehicle battery manufacturer, has started a price war in the w...

Hanwha Q Cells Co., a solar power unit of South Korean conglomerate Hanwha Group, has signed a contract to transfer technology licenses to Chinese s...

South Korea’s health and drug safety authority has cleared Somzz to treat patients with sleep disorders, a dynamic move that is expected to vi...

Ford Motor Co. said on Tuesday it has stopped production and shipments of the F-150 Lightning electric pickup truck due to a possible battery issue,...

Vaxcell-Bio Therapeutics, a South Korean company specializing in anti-cancer immunotherapy, announced on Wednesday its partnership with Cellid Co. t...

South Korea’s POSCO Group has joined hands with an Australian company to work on an electric vehicle battery material project in the US as it ...

South Korea's biohealth company HK inno.N said on Tuesday that its gastroesophageal reflux disease (GERD) treatment K-CAB (active ingredient: tegopr...

SK Plasma Co. Ltd., a South Korean company specializing in the production of plasma derivatives from human plasma, is expanding its product portfoli...

South Korean pharmaceuticals firm Hanall Biopharma Co. is investing in Interon Laboratories, a US biotech firm that finds and develops treatments fo...

South Korea's HLB Co. announced on Thursday that the combination therapy of its drug candidate rivoceranib and Jiangsu Hengrui Pharmaceuticals Co., ...

South Korea’s secondary battery ingredient makers are rushing to develop silicon anode materials, next-generation core substances that signifi...

South Korea's bio firm GC Cell announced on Wednesday that its US affiliate Artiva Biotherapeutics has received fast-track designation from the US F...

South Korean drugmaker Hanmi Pharmaceutical Co.’s neutropenia agent, Rolvedon (eflapegrastim-xnst), is forecast to achieve about $10 million i...

POSCO Chemical Co., a battery material unit of South Korea’s steel giant POSCO Holdings Inc., and Samsung SDI Co., the world’s No. 6 ele...

South Korea's biotech companies Bridge Biotherapeutics Inc. and Pinotbio on Thursday said they will jointly develop new antibody-drug conjugates (AD...

Hanwha Solutions Corp., a unit of South Korea’s chemicals-to-construction conglomerate Hanwha Group, said on Thursday it has formed a strategi...

South Korea's biohealth company HK inno.N said on Wednesday that it has signed an agreement with Spanish pharmaceutical company mAbxience SA to intr...

South Korea's Inventage Lab, a developer of a drug delivery system platform, on Wednesday said it received approval from the Human Research Ethics C...

ST Pharm Co., a South Korean company specializing in contract development and manufacturing of drug ingredients, has signed a supply contract worth ...

LG Chem Ltd. is set to complete its $571 million purchase of the US biotech firm AVEO Pharmaceuticals Inc. on Friday, which would strengthen its ant...

GC Biopharma Corp. said on Wednesday that its Sanfilippo type A treatment, which is under joint development with Novel Pharma, a bio-venture special...

South Korean biotech company MedPacto Inc. ’s Vactosertib monotherapy for osteosarcoma patients has been designated as a fast-track developmen...

Celltrion Inc. announced on Monday it applied to the European Medicines Agency (EMA) for approval of a 20 mg/0.2 mL formulation of Yuflyma, a biosim...

SK Chemicals said on Monday that it has launched Remitch in orally disintegrating tablets, a treatment for intractable uremic pruritus (uremia itchi...